Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

World Anti-Doping Agency: 99 Meldonium Cases Found This Year

By Drug Discovery Trends Editor | March 15, 2016

In this Sunday, Jan. 24, 2016, file photo, Maria Sharapova of Russia celebrates after defeating Belinda Bencic of Switzerland in their fourth round match at the Australian Open tennis championships in Melbourne, Australia. Sharapova's racket supplier became the first main sponsor to publicly back the five-time Grand Slam champion after she admitted to failing a doping test. Austria-based company Head announced Thursday, March 10, 2016, it was planning to extend its sponsorship deal, three days after Sharapova revealed her use of the banned substance meldonium. (AP Photo/Aaron Favila)The drug at the center of the Maria Sharapova doping case has produced 99 positive tests so far this year, the World Anti-Doping Agency said Friday.

WADA spokesman Ben Nichols told The Associated Press in an e-mail that since meldonium was banned on Jan. 1 “there have been 99 adverse analytical findings” for the drug.

Nichols did not provide details of who has tested positive.

Meldonium, a blood-flow boosting drug produced in Latvia, is most common in Eastern European and former Soviet countries, where it is often available over the counter.

Seven of the 16 confirmed cases come from Russian athletes, including Sharapova, who admitted she had tested positive on Monday at a news conference. Sharapova said she has been taking meldonium for 10 years for various health issues and did not know it had been banned.

Other cases involve athletes from Ukraine, Georgia and Sweden.

Athletes who fail doping tests can face a ban of up to four years for a first offense, but substantial reductions can be imposed if they demonstrate that they did not intend to enhance their performance.

Sharapova is one of four Olympic medalists to have tested positive for meldonium. The others are Russian speedskater Semyon Elistratov, Russian ice dancer Ekaterina Bobrova and Georgian wrestler Davit Modzmanashvili.

WADA announced in September that meldonium, which was once used to help boost the endurance of Soviet troops, would be banned from 2016, citing evidence of the drug’s performance-enhancing benefits and widespread use in international sports.

Since Sharapova announced that she tested positive, the Russian government has criticized WADA. Foreign Minister Sergei Lavrov said Thursday that meldonium should never have been banned, arguing that it doesn’t enhance performance.

Within Russia, senior figures have been shifting blame between federation officials, team doctors and the athletes themselves. The head of the speedskating federation has said he suspects some people of spiking their teammates with meldonium so that they would test positive.

On Friday, Sports Minister Vitaly Mutko told the Interfax news agency that an investigation was under way into how so many athletes tested positive.

“I share collective responsibility,” he said, adding that the answer was not to reduce Russia’s reliance on sports medications but to develop new drugs that are not banned.

“When we aren’t creating our own, we get caught using Latvian or Chinese substances,” Mutko said. “We should have our own scientific research activity in high-level sport.”

Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE